Laformin GV 2mg/500mg/0.2mg Tablet ER
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Laformin GV 2mg/500mg/0.2mg Tablet ER
Diabex Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Diabex Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by sweating, dizziness, headache, and tremors. Carry a fast-acting glucose source (e.g., sugary snacks, juice) to counter this. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are recommended as directed by your doctor.
Uses of Laformin GV 2mg/500mg/0.2mg Tablet ER
Managing type 2 diabetes
Major Benefits of Laformin GV 2mg/500mg/0.2mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Laformin GV 2mg/500mg/0.2mg Extended-Release Tablets. Ingest the tablets whole; do not break, crush, or chew them. Administer on an empty stomach.
Common Side effects of Laformin GV 2mg/500mg/0.2mg Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Laformin GV 2mg/500mg/0.2mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Laformin GV 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Laformin GV 2mg/500mg/0.2mg Tablet ER works:
Extended-release Laformin GV tablets (2mg/500mg/0.2mg) contain a triple-drug antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Laformin GV 2mg/500mg/0.2mg ER tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Laformin GV tablets (2mg/500mg/0.2mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Laformin GV tablets (2mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Patients with kidney disease should likely avoid Laformin GV 2mg/500mg/0.2mg Tablet ER, as its use may be unsafe. Medical advice is recommended. Specifically, Laformin GV 2mg/500mg/0.2mg Tablet ER is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Laformin GV 2mg/500mg/0.2mg Extended-Release tablets cautiously. Dosage modification may be necessary. A physician's consultation is advised. In those with mild to moderate liver disease, Laformin GV 2mg/500mg/0.2mg Extended-Release tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Laformin GV 2mg/500mg/0.2mg Tablet ER :
Should you forget to take your Laformin GV 2mg/500mg/0.2mg Extended-Release tablet, administer it immediately upon recollection. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Never take a double dose.
Facts to Know About Laformin GV 2mg/500mg/0.2mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently